Glucagon-like peptide-1 receptor agonists, commonly referred to as GLP-1s, are becoming increasingly widespread, with the most notable examples including Ozempic, Wegovy, and Saxenda
Specifically, it is an investigational triple hormone receptor agonist that activates the GLP-1, GIP, and glucagon receptors through one molecule
Inoue T, Inoguchi T, Sonoda N, Hendarto H, Makimura H, Sasaki S, Yokomizo H, Fujimura Y, Miura D, Takayanagi R
Those differences in manufacturing, ingredients and formulations are exactly what has some clinicians worried about their patients use of compounded GLP-1s
You could extend the maintenance phase or continue titrating to 12mg depending on your response and goals
Our full guide to stopping Wegovy covers the tapering process, withdrawal symptoms and how to keep the weight off in detail